Aim 1 Identifying druggable Targets for potential ARSACS treatment
Aim 2 Characterize pathophysiology for future druggable target development
Duration : 2 year funded project Grant: $50,000 Contact:
Dr. Anne McKinney, Department of Pharmacology and Therapeutics, McGill University Bellini Life Sciences Bldg
3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1
Tel: (514)-398-5685; Fax: (514)-398-2045; Email: anne.mckinney@mcgill.ca
